The most anticipated drug launches of 2024
The Top Line
00:00
Declining Anticipated Sales and Complexity of Drug Launches
The chapter discusses a report by Evaluate that provides estimates for potential sales of drugs launching in 2024. The report highlights a significant decline in anticipated sales since 2022 and attributes it to various factors such as tough disease targets, niche drugs, regulatory environment, manufacturing concerns, and failures in trials.
Transcript
Play full episode
